Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats

Journal of Psychopharmacology

Volumn 19, Issue 5, 2005, Pages 448-454

  Perfumi, Marina ^a   Mattiolli, Laura ^a   Cucculelli, Marino ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Alcohol intake; Alcohol preferring rats; Hypericum; Naltrexone; Opioid receptor antagonists; St. John's wort

Indexed keywords

ALCOHOL; HYPERICUM PERFORATUM EXTRACT; NALTREXONE; OPIATE ANTAGONIST;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; FOOD INTAKE; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ALCOHOL DRINKING; ANIMALS; BICYCLO COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; HYPERICUM; INJECTIONS, INTRAPERITONEAL; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PHLOROGLUCINOL; PLANT EXTRACTS; RATS; TERPENES; TIME FACTORS; TREATMENT OUTCOME;

EID: 25844490852     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105056519     Document Type: Article

References (39)

1. Barnes J, Anderson L A, Phillipson J D (2001) St. John's Wort (Hypericum perforatum L.) a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53: 583-600
2. Colombo G (1997) Ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol 32: 443-453
3. Cowen M S, Rezvani A H, Jarrott B, Lawerence A J (1999) Ethanol consumption by fawn-hooded rats following abstinence: effects of naltrexone and changes in mu-opioid receptor density. Alcohol Clin Exp Res 23: 1008-1014
4. Davidson D, Amit Z (1997) Naltrexone blocks acquisition of voluntary ethanol intake in rats. Alcohol Clin Exp Res 21: 677-683
5. De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch KR (1999) Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur J Neuropsychopharmacol 10: 37-42
6. Farren C K, O'Malley S (2002) A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence. Am J Addict 11(3): 228-234
7. Flausino O A, Zangrossi Jr H, Salgano J V, Viana M B (2002) Effect of acute and chronic treatment with Hypericum perforatum L. (LI160) on different anxiety-related responses in rats. Pharmacol Biochem Behav 71: 251-257
8. Froehlich J C, O'Malley S, Hyytia P, Davidson D, Farren C (2003) Preclinical and clinical studies on naltrexone: what have they taught each other? Alcohol Clin Exp Res 27: 533-539
9. Gessa G L, Colombo G, Fadda F (1991) Rats lines genetically selected for difference in voluntary ethanol consumption. In Meltzer H Y, Nerozzi D (eds), Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders. Excerpta Medica, Amsterdam, pp. 193-200
10. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129: 99-111
11. Hyytia P (1993) Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45: 697-701
12. Hyytia P, Ingman K, Soini S L, Laitinen J T, Korpi E R (1999) Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Naunyn-Schmiedeberg's Arch Pharmacol 360: 391-401
13. Johnson B A, Ait-Daoud N, Prihoda T (2000) Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcohol Clin Exp Res 24: 737-742
14. Koob G F, Roberts A J, Schulteis G, Parson L H, Geyser C J, Hyytia P, Merlo-Pich E, Weiss F (1998) Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22: 3-9
15. Krishnan-Sarin S, Wand G S, Li X W, Portoghese P S, Froehlich J C (1998) Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav 50: 627-635
16. 2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide. Alcohol 13: 53-57
17. Lukas S E, Moreton J E (1979) A technique for chronic intragastric drug administration in the rat. Life Sci 25: 593-600
18. Mason G A, Rezvani A H, Grady D R, Garbutt J C (1994) The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance. Alcohol Clin Exp Res 18: 1196-1201
19. O'Brien C P, Volpicelli L A, Volpicelli J R (1996) Naltrexone in the treatment of alcoholism: a clinical review. Alcohol 13: 35-39
20. O'Malley S S, Jaffe A J, Chang G, Scottenfeld R S, Meyer R E, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881-887
21. Overstreet D H, Kampov-Polevoy A B, Rezvani A H, Braun C, Bartus R T, Crews F T (1999) Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding. Alcohol Clin Exp Res 23: 1761-1771
22. Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Massi M (2000) Effects of Hypericum perforation extract on ethanol intake and on behavioral despair: a search for the neurochemical systems involved. Pharmacol Biochem Behav 66: 105-111
23. Parkes J H, Sinclair J D (2000) Reduction of alcohol drinking and up-regulation of opioid receptors by oral naltrexone in AA rats. Alcohol 21: 215-221
24. Perfumi M, Ciccocioppo R, Angeletti S, Cucculelli M, Massi M (1999) Effect of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol Alcohol 34: 690-698
25. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol 36: 199-206
26. Perfumi M, Santoni M, Ciccocioppo R, Massi M (2002) Blockade of gamma-aminobutyric acid receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rats. Alcohol Alcohol 37: 540-546
27. 2-extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats. Alcohol Clin Exp Res 27: 1554-1562
28. Pulvirenti L, Kastin A J (1988) Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference. Pharmacol Biochem Behav 31: 129-134
29. Rezvani A H, Mason G A, Garbutt J C, Janowsky D S, Overstreet D H (1993) Reduction of tolerance to anti-craving drugs for alcohol. Alcohol Clin Exp Res 17: 515-522
30. Rezvani AH, Overstreet DH, Yang Y, Clark Jr E (1999) Attenuation of alcohol intake by the extract of Hypericum Perforatum (St John's Wort) in two different strains of alcohol preferring rats. Alcohol Alcohol 34: 699-705
31. Rezvani A H, Overstreet D H, Mason G A, Janowsky DS , Hamedi M, Clark Jr E, Yang Y (2000) Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol 35: 76-83
32. Rezvani A H, Overstreet D H, Perfumi M, Massi M (2003) Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem Behav 75: 593-606
33. Rodriguez-Landa J F, Contreras C M (2003) A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine 10: 688-699
34. Stromberg M F, Mackler S A, Volpicelli J R, O'Brien C P (2001) Effect of acramposate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 23: 109-116
35. Stromberg M F, Volpicelli J R, O'Brien C P (1998) Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Exp Clin Res 22: 2186-2191
36. Volpicelli J R, Alterman A I, Hayashida M, O'Brien C P (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876-880
37. Winterhoff H, Butterweck V, Nahrstedt A, Gumbinger H G, Schulz V, Erping S, Bobhammer F and Weiligmann A (1995) Pharmacologische Untersuchungen zur antidepressiven Wirkung von Hypericum perforatum L. In Loew D, Rietbrock N (eds), Phytopharma in Forschung und klinischer Anwendung, Steinkopf, Darmstadt, pp. 39-56
38. Wright C W, Gott M, Grayson B, Hanna M, Smith A G, Sunter A, Neill J C (2003) Correlation of hyperforin content of Hypericum perforatum (St. John's wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. J Psychopharmacol 17: 403-408
39. Zink R W, Rohrbach K, Froehlich J C (1997) Naltrexone and fluoxetine act synergistically to decrease alcohol intake. Alcohol Clin Exp Res 2 (Suppl): 105